Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2005
Business Overview: Herbalife is a global network marketing company selling weight management, nutritional supplements ("Inner Nutrition"), and personal care products ("Outer Nutrition") through over one million independent distributors in 60 countries. The company operates as a single reporting segment.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2005 |
Six Months Ended June 30, 2005 |
Three Months Ended June 30, 2004 |
Six Months Ended June 30, 2004 |
|---|---|---|---|---|
| Net Sales | $384.7 million | $756.7 million | $324.2 million | $648.2 million |
| Gross Profit | $307.3 million | $603.6 million | $257.9 million | $518.3 million |
| Gross Margin | 79.9% | 79.8% | 79.6% | 80.0% |
| Operating Income | $52.4 million | $103.5 million | $38.2 million | $74.9 million |
| Net Income | $22.8 million | $36.1 million | $12.1 million | $11.6 million |
| Diluted EPS | $0.32 | $0.50 | $0.22 | $0.21 |
| Cash from Operations | N/A | $70.2 million | N/A | $65.6 million |
| Cash & Equivalents (End of Period) | $100.7 million | $100.7 million | $157.1 million | $157.1 million |
| Total Debt (Current + Long Term) | $336.3 million | $336.3 million | $486.2 million | $486.2 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 18.7% for the quarter and 16.7% for the six-month period compared to 2004. Growth was driven by strong distributor recruitment/retention, new product launches (ShapeWorks, NiteWorks, Liftoff, NouriFusion), and favorable foreign currency exchange rates.
- Profitability: Net income increased 88.4% for the quarter and 211% for the six-month period. Excluding a $5.5 million non-cash tax charge related to a China subsidiary restructuring and recapitalization expenses, adjusted net income growth was significantly higher (133.9% for the quarter).
- Debt Reduction: Total debt decreased from $486.2 million at year-end 2004 to $336.3 million at June 30, 2005. This reduction resulted from the redemption of $110 million of 9.5% Notes in February 2005 and prepayments of $35 million on the senior credit facility in Q2 2005.
- Regional Performance:
- The Americas: Sales increased 43.7% (Q3) and 35.2% (YTD), driven by Mexico and Brazil.
- Europe: Sales increased 3.2% (Q3) and 4.5% (YTD), though local currency sales declined in key markets like Germany and the Netherlands.
- Asia/Pacific: Sales increased 13.6% (Q3) and 21.6% (YTD), led by Taiwan and South Korea.
- Japan: Sales declined 6.0% (Q3) and 8.5% (YTD), continuing a five-year downward trend.
Guidance, Outlook, and Risks
- Outlook: Management expects 2005 net sales in the Americas to continue growing. Europe sales are expected to be flat to slightly positive. Asia/Pacific Rim sales are expected to increase. Selling, General & Administrative (SG&A) expenses are expected to increase approximately 7% over 2004 levels but decrease as a percentage of net sales.
- Capital Expenditures: Expected to be up to $40.0 million in 2005, focused on IT systems, distributor tools, and facility expansion in China and Japan.
- Key Risks & Contingencies:
- Litigation: Two class-action lawsuits pending (Mey v. Herbalife regarding telemarketing; Minton v. Herbalife regarding "endless chain schemes"). Management believes it has meritorious defenses.
- Product Liability/Regulatory: Voluntary withdrawal of "Sesame & Herb" tablets in Israel due to anecdotal liver dysfunction reports. The Israeli Ministry of Health has found no causal link, but the review continues.
- Tax Audits: Subsidiaries are subject to audits proposing significant additional taxes; management is contesting these vigorously.
- Foreign Exchange: A strengthening U.S. dollar negatively impacts reported sales and margins. The company uses derivatives to hedge these risks.
Investor Verification Checklist
- Debt Covenants: Verify compliance with leverage and fixed charge coverage ratios under the new $225 million senior credit facility.
- Japan Market Trend: Monitor the effectiveness of new initiatives to reverse the five-year sales decline in Japan.
- Legal Exposure: Track developments in the Minton and Mey class-action lawsuits and potential impact on distributor relationships.
- Regulatory Status: Confirm the final outcome of the Israeli Ministry of Health review regarding the Sesame & Herb product.
- Stock-Based Compensation: Note the upcoming adoption of SFAS 123R in 2006, which may impact future net income reporting.